This phase I clinical trial is designed to evaluate the safety and tolerability of VLP Peanut in healthy subjects and in subjects with peanut allergy (PA). This clinical trial will evaluate the immunotoxicity profile of VLP Peanut in healthy subjects and assess the immunotoxicity profile and the degree of reactogenicity (allergenicity) in subjects with PA. This clinical trial will also explore preliminary proof of efficacy of VLP Peanut in subjects with PA.
Protocol Amendment History
8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2022-07-25; most recent amendment 2026-03-12.
Status change: Recruiting → Active, Not Recruiting2026-03-12
Status change: Not Yet Recruiting → Recruiting2022-10-06